睡眠障碍-抑郁共病与血管健康相关指标的关联:基于NHANES数据的性别与年龄分层分析OA
Association between sleep disorder-depression comorbidity and cardiovascular health indicators:Gender-and age-stratified analysis based on NHANES data
目的:心血管疾病(cardiovascular disease,CVD)是全球主要健康威胁,而睡眠障碍与抑郁共病可能进一步加剧心血管风险,且该关联受性别和年龄因素影响.本研究旨在利用美国国家健康与营养调查(National Health and Nutrition Examination Survey,NHANES)2013-2018年数据,评估睡眠障碍-抑郁共病与心血管健康指标的关联,并分析不同性别和年龄人群之间的差异特征.方法:纳入NHANES 2013-2018中年龄≥18岁、数据完整的参与者,排除严重认知功能障碍者.通过睡眠问卷评估睡眠状况(睡眠时长<7 h或>9 h、睡眠质量差),患者健康问卷(Patient Health Questionnaire,PHQ-9)评估抑郁状况(PHQ-9评分≥10为抑郁).同时满足睡眠异常和抑郁者为共病组,其余为非共病组.收集血压、肥胖指标、血脂及超敏C反应蛋白(high-sensitivity C-reactive protein,hs-CRP)等心血管健康指标数据.采用多因素Logistic回归分析共病状态与心血管结局的关联强度,并按性别和年龄进行分层分析.结果:共病组的年龄显著大于非共病组[(56.2±12.3)岁 vs(45.8±13.5)岁],共病组的女性占比(62.3%vs 48.5%)、高血压患病率(48.7%vs 22.6%)、肥胖率(52.4%vs 30.4%)及hs-CRP水平[3.20(1.80,5.40)mg/L vs 1.50(0.80,2.60)mg/L]均显著高于非共病组(均P<0.001).共病组的高血压(OR=2.89,95%CI 2.43~3.44)、肥胖(OR=3.12,95%CI 2.65~3.67)、高甘油三酯(OR=2.56,95%CI 2.21~2.96)及高hs-CRP(OR=3.45,95%CI 2.98~4.00)风险显著高于非共病组(均P<0.001).女性(OR=3.21,95%CI 2.64~3.91)及高龄(≥65岁;OR=3.56,95%CI 2.89~4.38)人群高血压风险更高(均P<0.001),提示共病状态与心血管相关指标的关联存在性别和年龄异质性.结论:睡眠障碍-抑郁共病与多项心血管健康不良指标显著相关,且该关联在女性及老年人群中更为明显.hs-CRP水平升高提示炎症反应可能参与睡眠障碍-抑郁共病与血管健康损害之间的联系.
Objective:Cardiovascular disease(CVD)is a leading global health threat.Comorbidity of sleep disorders and depression may further exacerbate cardiovascular risk,and this association may be influenced by gender and age.This study aims to evaluate the association between sleep disorder-depression comorbidity and cardiovascular health indicators using data from the National Health and Nutrition Examination Survey(NHANES)2013-2018,and to examine differences across gender and age groups. Methods:Participants aged≥18 years with complete data were included from NHANES 2013-2018,excluding those with severe cognitive impairment.Sleep status was assessed via questionnaire(sleep duration<7 h or>9 h,poor sleep quality),and depression was assessed using the Patient Health Questionnaire-9(PHQ-9;PHQ-9≥10 indicated depression).Participants with both sleep abnormalities and depression were defined as the comorbidity group,and the remainder as the non-comorbidity group.Cardiovascular health indicators collected included blood pressure,obesity indices,blood lipids,and high-sensitivity C-reactive protein(hs-CRP).Multivariate Logistic regression was used to analyze the association between comorbidity status and cardiovascular outcomes,with stratified analyses by gender and age. Results:The comorbidity group was significantly older than the non-comorbidity group[(56.2±12.3)years vs(45.8±13.5)years],and had a higher proportion of females(62.3%vs 48.5%).Rates of hypertension(48.7%vs 22.6%),obesity(52.4%vs 30.4%),and hs-CRP levels[3.20(1.80,5.40)mg/L vs 1.50(0.80,2.60)mg/L]were significantly higher in the comorbidity group than in the non-comorbidity group(all P<0.001).Sleep disorder-depression comorbidity was significantly associated with increased risk of hypertension(OR=2.89,95%CI 2.43 to 3.44),obesity(OR=3.12,95%CI 2.65 to 3.67),hypertriglyceridemia(OR=2.56,95%CI 2.21 to 2.96),and elevated hs-CRP(OR=3.45,95%CI 2.98 to 4.00)(all P<0.001).Women(OR=3.21,95%CI 2.64 to 3.91)and older adults(≥65 years;OR=3.56,95%CI 2.89 to 4.38)showed higher hypertension risk,suggesting gender-and age-related heterogeneity in the association between comorbidity and cardiovascular health indicators(all P<0.001). Conclusion:Sleep disorder-depression comorbidity is significantly associated with multiple adverse cardiovascular health indicators,with stronger associations observed in women and older adults.Elevated hs-CRP levels suggest that inflammatory responses may contribute to the link between sleep disorder-depression and vascular health impairment.
陈雷;邓鸿儒;孟令丙
首都医科大学复兴医院血管外科,北京市 100038首都医科大学复兴医院血管外科,北京市 100038中国医学科学院阜外医院国家心血管疾病临床研究中心,心血管代谢医学中心,北京 100037
医药卫生
睡眠障碍抑郁心血管疾病联合影响炎症反应性别差异年龄分层NHANES
sleep disorderdepressioncardiovascular diseasecombined effectinflammatory responsegender differencesage stratificationNHANES
《临床与病理杂志》 2026 (4)
505-513,9
国家自然科学基金(82400543,82304864)中国医学科学院医学与健康科技创新工程项目(2025-12M-XHXX-034).This work was supported by the National Natural Science Foundation(82400543,82304864)and the Chinese Academy of Medical Sciences Innovation Fund for Medical Science and Health(2025-12M-XHXX-034),China.
评论